Compass Therapeutics, Inc. Share Price
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.270 USD | +4.13% |
|
+9.13% | -57.73% |
| 29/06 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000E Growth Benchmark | CI |
| 29/06 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000 Growth Benchmark | CI |
| Market Cap | 41Cr 36Cr 33Cr 31Cr 58Cr 3.89TCr 59Cr 394.28Cr 153.28Cr 1.91TCr 153.45Cr 150.15Cr 6.59TCr | P/E 2026 * |
-5.21x | P/E 2027 * | -4.89x |
|---|---|---|---|---|---|
| Enterprise Value | 26Cr 23Cr 21Cr 19Cr 37Cr 2.46TCr 37Cr 249.61Cr 97Cr 1.21TCr 97Cr 95Cr 4.17TCr | EV / Sales 2026 * |
-126x | EV / Sales 2027 * | 11x |
| Free-Float |
87.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Compass Therapeutics, Inc.
| 1 day | +4.13% | ||
| 1 week | +9.13% | ||
| Current month | +3.65% | ||
| 1 month | +6.57% | ||
| 3 months | -58.35% | ||
| 6 months | -56.09% | ||
| Current year | -57.73% |
| 1 week | 2.07 |  | 2.29 |
| 1 month | 1.88 | | 2.29 |
| Current year | 1.61 | | 6.88 |
| 1 year | 1.61 | | 6.88 |
| 3 years | 0.76 | | 6.88 |
| 5 years | 0.76 | | 6.88 |
| 10 years | 0.76 | | 11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 28/05/2024 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 09/12/2024 |
Bing Gong
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 01/01/2014 |
Phil Ferneau
BRD | Director/Board Member | 64 | 01/01/2015 |
Carl Gordon
CHM | Chairman | 61 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/04 | Buy | General Counsel | 25,000 | 0.0139% | ||
| 29/04 | Buy | Controller/Auditor | 15,000 | 0.0083% | ||
| 08/02 | Tax | Chief Executive Officer | 36,687 | 0.0206% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.13% | +9.13% | -18.35% | -27.24% | 41Cr | |
| +0.68% | +5.92% | +77.86% | +139.22% | 5.91TCr | |
| +2.32% | +5.03% | +75.26% | +91.40% | 5.52TCr | |
| +3.86% | +6.93% | -11.32% | -9.53% | 2.47TCr | |
| +4.30% | +7.95% | +14.11% | +437.83% | 2.42TCr | |
| +4.74% | +13.68% | +43.36% | -4.67% | 1.97TCr | |
| -0.29% | +9.78% | +43.90% | -28.41% | 1.76TCr | |
| 0.00% | +20.78% | +186.15% | +361.42% | 1.62TCr | |
| +6.72% | +19.38% | +37.85% | - | 1.48TCr | |
| +3.50% | +1.97% | +21.02% | +191.95% | 1.4TCr | |
| Average | +3.00% | +8.68% | +46.98% | +128.00% | 2.46TCr | |
| Weighted average by Cap. | +2.47% | +6.48% | +58.20% | +136.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | -20.57L -17.98L -16.53L -15.4L -29.22L -20Cr -29.66L -1.98Cr -77.13L -9.63Cr -77.22L -75.56L -33Cr | 2.53Cr 2.21Cr 2.03Cr 1.89Cr 3.59Cr 240.6Cr 3.64Cr 24Cr 9.47Cr 118.27Cr 9.48Cr 9.28Cr 407.53Cr |
| Net income | -8.24Cr -7.21Cr -6.62Cr -6.17Cr -12Cr -784.92Cr -12Cr -80Cr -31Cr -385.83Cr -31Cr -30Cr -1.33TCr | -8.96Cr -7.83Cr -7.2Cr -6.71Cr -13Cr -852.81Cr -13Cr -86Cr -34Cr -419.2Cr -34Cr -33Cr -1.44TCr |
| Net Debt | -15Cr -13Cr -12Cr -11Cr -21Cr -1.43TCr -22Cr -144.67Cr -56Cr -702.04Cr -56Cr -55Cr -2.42TCr | -13Cr -12Cr -11Cr -9.88Cr -19Cr -1.26TCr -19Cr -127.31Cr -49Cr -617.8Cr -50Cr -48Cr -2.13TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $2.270 | +4.13% | 29,39,846 |
| 01/26/01 | $2.180 | -0.46% | 23,79,040 |
| 30/26/30 | $2.190 | +1.39% | 38,88,526 |
| 29/26/29 | $2.160 | +3.85% | 28,36,724 |
| 26/26/26 | $2.080 | +0.48% | 76,06,102 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
